|
SB2
|
16
|
Mom 22 / Mom 23
|
Eih3
|
ethanol induced hypothermia 3
|
|
Mom 22 / Mom 23
|
Bwtn1
|
body weight at necropsy 1
|
|
Mom 22 / Mom 23
|
Aod1a
|
autoimmune ovarian dysgenesis 1a
|
|
Mom 22 / Mom 23
|
Skts-fp3
|
skin tumor susceptibility in FVB and PWK 3
|
|
Mom 22 / Mom 23
|
Eae41
|
experimental allergic encephalomyelitis susceptibility 41
|
|
Mom 22 / Mom 23
|
Diobq
|
diet-induced obesity QTL
|
|
Mom 22 / Mom 23
|
Dice1b
|
determination of interleukin 4 commitment 1b
|
|
Mom 23
|
Eae11
|
experimental allergic encephalomyelitis susceptibility 11
|
|
Mom 23
|
Lith14
|
lithogenic gene 14
|
|
Mom 23
|
Pod
|
plasticity of ocular dominance
|
| |
Sluc27
|
susceptibility to lung cancer 27
|
| |
Etia
|
ethanol induced activation
|
| |
Bpq9
|
blood pressure QTL 9
|
| |
Tgq28
|
triglyceride QTL 28
|
| |
Pgia10
|
proteoglycan induced arthritis 10
|
|
SB3
|
9
|
Mom 26
|
Sles4
|
systemic lupus erythmatosus suppressor 4
|
|
Mom 26
|
Bmiq8
|
body mass index QTL 8
|
|
Mom 26
|
Obq5
|
obesity QTL 5
|
|
Mom 26
|
Igan3
|
IgA nephropathy 3
|
|
Mom 26
|
Elnv
|
epilepsy naive
|
|
Mom 26
|
V125Dq7
|
vitamin D active form serum level QTL 7
|
|
Mom 26
|
V125Dq8
|
vitamin D active form serum level QTL 8
|
|
SB3
|
10
|
Mom 21
|
Obsty3
|
obesity 3
|
|
Mom 21
|
Sysbp1
|
systolic blood pressure 1
|
|
Mom 21
|
W3q11
|
weight 3 weeks QTL 11
|
| |
W6q6
|
weight 6 weeks QTL 6
|
|
Mom 21
|
W10q5
|
weight 10 weeks QTL 5
|
|
Mom 21
|
Egq7
|
early growth QTL 7
|
|
Mom 21
|
Hrtq3
|
heart weight QTL 3
|
|
Mom 21
|
Kidpq2
|
kidney weight percentage QTL 2
|
|
Mom 21
|
Lvrq4
|
liver weight QTL 4
|
|
Mom 21
|
Scfpq1
|
subcutaneous fat pad percentage QTL 1
|
| |
Scc9
|
colon tumor susceptibility 9
|
| |
Eae34
|
experimental allergic encephalomyelitis susceptibility 34
|
| |
Lmblgq4
|
limb length QTL 4
|
| |
Lmblgq4
|
limb length QTL 4
|
| |
Angvq1
|
angiogenesis by VEGF QTL 1
|
| |
Phl2
|
progressive hearing loss 2
|
| |
Cia8
|
collagen induced arthritis QTL 8
|
| |
Wght9
|
weight 9
|
| |
Bbaa18
|
B.burgdorferi-associated arthritis 18
|
| |
Skull14
|
skull morphology 14
|
| |
Lmb4
|
lupus in MRL and B6 F2 cross, QTL 4
|
| |
Lifespan2
|
life span 2
|
| |
Pbwg16
|
postnatal body weight growth 16
|
| |
Hpcr2
|
hepatocarcinogen resistance 2
|
| |
Jckm3
|
juvenile cystic kidney modifier 3
|
| |
Ath17
|
atherosclerosis 17
|
| |
Eae17
|
experimental allergic encephalomyelitis susceptibility 17
|
| |
Hfhl4
|
high-frequency hearing loss 4
|
| |
Clfrhl1
|
click-frequency hearing loss 1
|
| |
Lfhl1
|
low-frequency hearing loss 1
|
| |
Mfhl1
|
medium-frequency hearing loss 1
|
| |
Obrq12
|
obesity resistance QTL 12
|
| |
Pcholq4
|
plasma cholesterol QTL 4
|
| |
Gluq1
|
blood glucose QTL 1
|
| |
Bsc1
|
brain size control 1
|
| |
El3
|
epilepsy 3
|
| |
Insq9
|
insulin QTL 9
|
| |
Aem3
|
anti-erythrocyte autoantibody modifier 3
|
| |
Ssrq4
|
stress response QTL 4
|
| |
Pwgrq19
|
post-weaning growth rate QTL 19
|
| |
Tesq3
|
testis weight QTL 3
|
| |
Espq3
|
embryo survival preimplantation QTL 3
|
| |
Estoq3
|
embryo survival total QTL 3
|
| |
Egq9
|
early growth QTL 9
|
| |
Lgaq5
|
late growth adjusted QTL 5
|
| |
W10q8
|
weight 10 weeks QTL 8
|
| |
W6q8
|
weight 6 weeks QTL 8
|
| |
Cia29
|
collagen induced arthritis QTL 29
|
| |
Igf1sl2
|
IGF-1 serum levels 2
|
| |
Ltpr5a
|
Leishmania tropica response 5a
|
| |
Ltpr5
|
Leishmania tropica response 5
|
| |
Lgth11
|
body length 11
|
| |
Vtbt9
|
vertebral trabecular bone trait 9
|
| |
Fembrs3
|
femur breaking strength 3
|
| |
Ednrbm1
|
endothelin receptor type B modifier 1
|
| |
Tmevp2
|
Theiler’s murine encephalomyelitis virus persistence 2
|
| |
Ogrq4
|
overall growth rate QTL 4
|
| |
Femwf3
|
femur work to failure 3
|
|
SB3
|
12
| |
Pifs1
|
peptide-induced fatal syndrome 1
|
| |
Tcq14
|
total cholesterol QTL 14
|
| |
Bmiq11
|
body mass index QTL 11
|
| |
Chldq7
|
cholesterol and HDL QTL 7
|
| |
Tglq5
|
triglyceride QTL 5
|
| |
Femwf9
|
femur work to failure 9
|
| |
Tmc1m3
|
Tmc1 modifier 3
|
|
Total Polyps
|
16
|
Mom 23
|
Eae11
|
experimental allergic encephalomyelitis susceptibility 11
|
|
Mom 22
|
Arrd3
|
age-related retinal degeneration 3
|
|
Mom 22 / Mom 23
|
Aod1a
|
autoimmune ovarian dysgenesis 1a
|
| |
Tauph
|
tau phosphorylation
|
|
Mom 23
|
Lith14
|
lithogenic gene 14
|
|
Mom 22
|
Remslp3
|
rapid eye movement sleep 3
|
| |
Etia
|
ethanol induced activation
|
| |
Pgia10
|
proteoglycan induced arthritis 10
|
| |
Renf2
|
renal failure 2
|
| |
Sluc27
|
susceptibility to lung cancer 27
|
| |
Bpq9
|
blood pressure QTL 9
|
|
Mom 22
|
Pcd4ts3
|
p-glycoprotein positive CD4 T cell subset 3
|
|
Mom 22
|
Ipng3
|
imprinted postnatal growth 3
|
| |
Tgq28
|
triglyceride QTL 28
|
|
Mom 23
|
Imraq3
|
immune response to AAV2 QTL 3
|
|
Mom 22 / Mom 23
|
Diobq
|
diet-induced obesity QTL
|
|
Mom 22 / Mom 23
|
Bwtn1
|
body weight at necropsy 1
|
|
Mom 22
|
Lp1
|
lymphocyte proliferation 1
|
|
Mom 22 / Mom 23
|
Dice1b
|
determination of interleukin 4 commitment 1b
|
| |
Lmr18
|
leishmaniasis resistance 18
|
|
Mom 23
|
Pod
|
plasticity of ocular dominance
|
|
Mom 22 / Mom 23
|
Eih3
|
ethanol induced hypothermia 3
|
|
Mom 22 / Mom 23
|
Skts-fp3
|
skin tumor susceptibility in FVB and PWK 3
|
| |
Cocia19
|
cocaine-induced activity, QTL 19
|
| |
Lmr18a
|
leishmaniasis resistance 18a
|
| |
Lmr18b
|
leishmaniasis resistance 18b
|
|
Mom 22 / Mom 23
|
Eae41
|
experimental allergic encephalomyelitis susceptibility 41
|
|
Total Polyps
|
12
| |
Ath6
|
atherosclerosis 6
|
| |
Circp1
|
circadian photosensitivity 1
|
| |
Cplaq10
|
circadian period of locomotor activity 10
|
| |
Pifs1
|
peptide-induced fatal syndrome 1
|
| |
Tcq14
|
total cholesterol QTL 14
|
| |
Bmiq11
|
body mass index QTL 11
|
| |
Chldq7
|
cholesterol and HDL QTL 7
|
| |
Tglq5
|
triglyceride QTL 5
|
| |
Femwf9
|
femur work to failure 9
|
| |
Tmc1m3
|
Tmc1 modifier 3
|
